ANX-510 (CoFactor) is a folate-based biomodulator drug being developed to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapy, 5-fluorouracil (5-FU). CoFactor use with 5-FU is being evaluated in clinical trials in first line treatment of metastatic colorectal cancer. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Calcium Levofolinate EP Impurity I Calcium salt and Cofactor. Its PubChem CID is 135540812.
Folitixorin calcium
| CAS No | 133978-75-3 |
|---|---|
| Molecular Formula | C20H21CaN7O6 |
| Molecular Weight | 495.50 g/mol |
| Synonyms | calcium (2S)-2-[[4-(3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
ANX-510 (CoFactor) is a folate-based biomodulator drug being developed to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapy, 5-fluorouracil (5-FU).
The listed CAS number is 133978-75-3.
The listed molecular formula is C20H21CaN7O6.
The listed molecular weight is 495.50 g/mol.
calcium (2S)-2-[[4-(3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioate.
The source lists Calcium Levofolinate EP Impurity I Calcium salt and Cofactor.